Prelude Therapeutics, Inc. (PRLD)
1.64
-0.06
(-3.53%)
USD |
NASDAQ |
Dec 10, 13:36
Prelude Therapeutics Market Cap: 103.10M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 18.51B |
| Nautilus Biotechnology, Inc. | 256.40M |
| Protalix Biotherapeutics, Inc. | 140.33M |
| ALX Oncology Holdings, Inc. | 81.87M |
| Erasca, Inc. | 905.04M |
Market Cap Related Metrics
| PS Ratio | 11.06 |
| Price to Book Value | 1.761 |
| Price | 1.64 |
| Earnings Yield | -98.37% |